Prevalence of Metabolic Syndrome and its Individual Features Across Different (Normal, Overweight, Pre-Obese and Obese) Body Mass Index (BMI) Categories in a Tertiary Hospital in the Philippines

Annabel Mata, Gabriel Jasul Jr.


Objective. This study aims to determine the prevalence of metabolic syndrome and its individual components across different BMI categories among patients seen at Wellness Center and Obesity and Weight Management Center, St. Luke’s Medical Center Quezon City.

Methodology.This was a 3-year retrospective study of patients seen at the institution from 2013 to 2016. The patients were divided according to Asia-Pacific BMI categories and presence of metabolic syndrome was determined as defined by NCEP/ATP III-AHA/NHLBI (2005).

Results. This study included a total of 1367 adult patients with the mean age of 53 (SD= 12.4). The overall prevalence of metabolic syndrome is 51.0%. Its prevalence across the different BMI categories are as follows: 29.6 % with Normal BMI (BMI 18.5-22.9 kg/m2), 38.9% in overweight (BMI 23-24.9 kg/m2), 56.9% in Pre-Obese (BMI 25-29.9 kg/m2) and 62.4% in Obese (BMI ≥30 kg/m2) subgroup. Presence of central obesity using the Asian cut-off has the highest prevalence among patients with metabolic syndrome across all categories. In the group with normal BMI, hypertension and elevated blood glucose were highest with central obesity being the least common but still with 7.3% of individuals meeting the criteria for central obesity.

Conclusion. There is high prevalence of metabolic syndrome even in patients with normal BMI. Diagnosis and screening for its individual components should not only be confined to individuals with higher BMI.


body mass index, metabolic syndrome, obesity

Full Text:

Abstract HTML PDF


Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, 1999-2016.

Ford ES. Giles WH, Mokdad AH. Increasing prevalence of metabolic syndrome among US adults. Diabetes Care. 2004;27(10):2444–9. PMID: 15451914.

Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome and risk of incident cardiovascular disease in non diabetic American Indians: The Strong Heart Study. Diabetes Care. 2003;26(3):861–7. PMID: 12610050.

Punzalan FER, Sy RG, Ty-Willing T. Prevalence of metabolic syndrome among adult Filipinos. Int Congress Series. 2004;1262:442-5.

Morales DD, Punzalan FE, Paz-Pacheco E, et al. Metabolic syndrome in the Philippine general population: Prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diabetes Vasc Dis Res. 2008;5(1):36–43. PMID: 18398811. https://doi/org/10.3132/dvdr.2008.007.

Araneta MR, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women: A high risk non obese population. Diabetes Care. 2002;25(3):494–9. PMID: 11874936.

Benziger CP, Bernabé-Ortiz A, Gilman RH, et al. Metabolic abnormalities are common among South American Hispanics subjects with normal weight or excess body weight: The CRONICAS cohort study. PLoS ONE. 2015;10(11):e0138968. PMCID: PMC4658165.

Palaniappian LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of Metabolic syndrome despite lower body mass index. Int J Obesity. 2011;35(3):393–400. PMID: 20680014. PMCID: PMC2989340.

Pagsisihan D, Sandoval MA, Paz-Pacgeco E, Jimeno C. Low indices of overweight and obesity are associated with cardiometabolic diseases among adult Filipinos in a rural community. J ASEAN Fed Endocr Soc. 2016;31(2):97-104.

Perera S, Lohsoonthorn V, Jiamjarasrangsi W, Lertmaharit S, Williams MA. Association between elevated liver enzymes and metabolic syndrome among Thai adults. Diabetes Metab Syndr. 2008;2(3):171-8. PMCID: PMC4137970. NIHMSID: NIHMS442249.

Wang J, Li X, Yang K, et al. Serum creatinine levels and risk of metabolic syndrome in a middle-aged and older Chinese population. Clinica Chimica Acta. 2015; 440:177-82.